ENTITY
Illumina Inc

Illumina Inc (ILMN US)

54
Analysis
Health CareUnited States
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
more
Refresh
08 May 2019 03:58

MergerTalk: 3 Merger Deals Involving PACB US, GNW US and STC US Look Attractive Plays For Arbs

At AlphaSituations, we look for unusual spreads in announced US M&A deals of  >$400MN in size with the intention of identifying and...

Logo
885 Views
Share
bearishS&P 500 INDEX
28 Nov 2018 00:20

U.S. Equity Strategy: Retest of October Lows Underway; Upgrading Financials

Our outlook remains cautious as we continue to expect heightened volatility and a potential retest of the February 2018 lows over the next several...

Logo
515 Views
Share
bullishS&P 500 INDEX
08 Aug 2018 04:51

S&P 500: Outlook Constructive but Concerns Remain

As the S&P 500 nears the 2,873 January high - a critical hurdle - short-term Sector leadership changes give us reason for pause. While we...

Logo
290 Views
Share
bullishMacrogen Inc
20 Jul 2018 16:20

CV Note: Macrogen (038290 KQ)

"Korea’s #1 and the world’s #5 NGS player" The world’s 5th ranked DNA sequencing service provider. Growing NGS (Next Generation Sequencing) market...

Logo
568 Views
Share
26 Jun 2018 15:55

Trade Risks Start to Impact, as China Biotech Ambitions Grow…

Cyclical indicators are softening this month - new orders index for the Philly Fed fell nearly 23 points while Japan’s PMI new export orders...

Logo
117 Views
Share
x